Bulletin
Investor Alert

AbbVie Inc.

NYS: ABBV

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 25, 2020, 7:44 p.m.

/zigman2/quotes/202428675/composite

$

86.30

Change

+0.07 +0.08%

Volume

Volume 502,901

Quotes are delayed by 20 min

/zigman2/quotes/202428675/composite

Previous close

$ 85.91

$ 86.23

Change

+0.32 +0.37%

Day low

Day high

$85.46

$86.86

Open

52 week low

52 week high

$62.55

$101.28

Open

Annual Financials for AbbVie Inc.

Fiscal year is January-December. All values USD millions. 20152016201720182019 5-year trend
Sales/Revenue 22.86B25.64B28.22B32.75B33.27B
Cost of Goods Sold (COGS) incl. D&A 4.7B5.81B6.81B7.56B7.61B
COGS excluding D&A 3.86B4.63B5.31B5.79B5.59B
Depreciation & Amortization Expense 836M1.19B1.5B1.77B2.02B
Depreciation 417M425M425M471M464M
Amortization of Intangibles 419M764M1.08B1.29B1.55B
Gross Income 18.16B19.82B21.41B25.2B25.66B
20152016201720182019 5-year trend
SG&A Expense 9.72B10.03B10.85B12.56B12.09B
Research & Development 4.1B4.23B5.01B5.23B5.38B
Other SG&A 5.62B5.8B5.84B7.33B6.71B
Other Operating Expense ---500M(340M)
Unusual Expense 1.36B704M1.86B5.56B4.23B
EBIT after Unusual Expense 7.08B9.09B(1.86B)6.58B9.69B
Non Operating Income/Expense 250M(281M)26M(237M)280M
Non-Operating Interest Income 33M82M146M204M275M
Equity in Affiliates (Pretax) -----
Interest Expense 719M1.01B1.15B1.35B1.82B
Gross Interest Expense 719M1.01B1.15B1.35B1.82B
Interest Capitalized -----
Pretax Income 6.65B7.88B7.73B5.2B8.43B
Income Tax 1.5B1.93B2.42B(490M)544M
Income Tax - Current Domestic 1.04B2.23B6.2B593M102M
Income Tax - Current Foreign 313M498M376M434M320M
Income Tax - Deferred Domestic 141M(792M)(4.9B)(1.5B)(137M)
Income Tax - Deferred Foreign 11M(4M)736M(20M)259M
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) (26M)(30M)(26M)(30M)(40M)
Consolidated Net Income 5.12B5.92B5.28B5.66B7.84B
Minority Interest Expense -----
Net Income 5.12B5.92B5.28B5.66B7.84B
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries 5.12B5.92B5.28B5.66B7.84B
Preferred Dividends -----
Net Income Available to Common 5.12B5.92B5.28B5.66B7.84B
EPS (Basic) 3.153.653.313.675.30
Basic Shares Outstanding 1.63B1.62B1.6B1.54B1.48B
EPS (Diluted) 3.133.633.303.665.28
Diluted Shares Outstanding 1.64B1.63B1.6B1.55B1.48B
EBITDA 9.28B10.98B12.07B13.9B15.93B
Link to MarketWatch's Slice.